NCT05308979View on ClinicalTrials.gov

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions
Overactive BladderUrinary Urge IncontinenceOveractive Bladder SyndromeUrinary Incontinence, UrgeUrge IncontinenceUrinary UrgencyUrinary Frequency
Interventions
DRUG

OnabotulinumtoxinA 100 UNT [Botox]

Intradetrusor (Bladder) Botox Injection at 1 vs 10 injection sites

Trial Locations (1)

92868

University of California Irvine Medical Center, Orange

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

St. Joseph Hospital of Orange

OTHER

lead

University of California, Irvine

OTHER